BUZZ - Merck shares rise after raising annual profit forecast and beating third-quarter expectations

Latest Updates

October 29 - ** Pharmaceutical company Merck MRK.N shares rose 5.4%, closing at $148.57

** The pharmaceutical giant raised its annual adjusted earnings per share forecast to the $2.77-$2.82 range (link), up from a prior expectation of $2.66-$2.76

** According to data compiled by London Stock Exchange Group (LSEG), the company reported third-quarter adjusted earnings per share of $2.49, surpassing Wall Street’s expectation of $2.08 per share

** Third-quarter revenue reached $18.1 billion, exceeding the average analyst forecast of $17.3 billion

**Including intraday fluctuations, MRK stock has risen 40% so far this year

(To assist non-native English speakers, Reuters provides automated translations of its reports into several other languages. As automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of automated translation texts and provides them solely for the convenience of readers. Reuters accepts no liability for any damage or loss arising from the use of automated translation functions.)